These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36853930)

  • 1. Use of a Liver-Targeting Immune-Tolerogenic mRNA Lipid Nanoparticle Platform to Treat Peanut-Induced Anaphylaxis by Single- and Multiple-Epitope Nucleotide Sequence Delivery.
    Xu X; Wang X; Liao YP; Luo L; Xia T; Nel AE
    ACS Nano; 2023 Mar; 17(5):4942-4957. PubMed ID: 36853930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a Liver-targeting Nanoparticle Platform to Intervene in Peanut-induced anaphylaxis through delivery of an Ara h2 T-cell Epitope.
    Liu Q; Wang X; Liao YP; Chang CH; Li J; Xia T; Nel AE
    Nano Today; 2022 Feb; 42():. PubMed ID: 36969911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen- and Epitope-Delivering Nanoparticles Targeting Liver Induce Comparable Immunotolerance in Allergic Airway Disease and Anaphylaxis as Nanoparticle-Delivering Pharmaceuticals.
    Liu Q; Wang X; Liu X; Liao YP; Chang CH; Mei KC; Jiang J; Tseng S; Gochman G; Huang M; Thatcher Z; Li J; Allen SD; Lucido L; Xia T; Nel AE
    ACS Nano; 2021 Jan; 15(1):1608-1626. PubMed ID: 33351586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization Model.
    Liu Q; Wang X; Liu X; Kumar S; Gochman G; Ji Y; Liao YP; Chang CH; Situ W; Lu J; Jiang J; Mei KC; Meng H; Xia T; Nel AE
    ACS Nano; 2019 Apr; 13(4):4778-4794. PubMed ID: 30964276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses.
    Li XM; Serebrisky D; Lee SY; Huang CK; Bardina L; Schofield BH; Stanley JS; Burks AW; Bannon GA; Sampson HA
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):150-8. PubMed ID: 10887318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic diversity between mouse strains allows identification of the CC027/GeniUnc strain as an orally reactive model of peanut allergy.
    Orgel K; Smeekens JM; Ye P; Fotsch L; Guo R; Miller DR; Pardo-Manuel de Villena F; Burks AW; Ferris MT; Kulis MD
    J Allergy Clin Immunol; 2019 Mar; 143(3):1027-1037.e7. PubMed ID: 30342892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread monoclonal IgE antibody convergence to an immunodominant, proanaphylactic Ara h 2 epitope in peanut allergy.
    Croote D; Wong JJW; Pecalvel C; Leveque E; Casanovas N; Kamphuis JBJ; Creeks P; Romero J; Sohail S; Bedinger D; Nadeau KC; Chinthrajah RS; Reber LL; Lowman HB
    J Allergy Clin Immunol; 2024 Jan; 153(1):182-192.e7. PubMed ID: 37748654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Ara h 2 with human-derived monoclonal antibodies prevents peanut-induced anaphylaxis in mice.
    Paolucci M; Wuillemin N; Homère V; Bieli D; Köhli A; Ballmer-Weber B; Waeckerle-Men Y; Pengo N; Kündig TM; Sonati T; Johansen P
    Allergy; 2023 Jun; 78(6):1605-1614. PubMed ID: 36704937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain matters in mouse models of peanut-allergic anaphylaxis: Systemic IgE-dependent and Ara h 2-dominant sensitization in C3H mice.
    Paolucci M; Homère V; Waeckerle-Men Y; Wuillemin N; Bieli D; Pengo N; Sonati T; Kündig TM; Johansen P
    Clin Exp Allergy; 2023 May; 53(5):550-560. PubMed ID: 36629248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term IgE immunological tolerance to peanut allergens: An alternative to Noon's daily desensitization paradigm.
    Chen SS; Lee D; Zhang H; Cao XH; DuPrez K
    Cell Immunol; 2022 Nov; 381():104611. PubMed ID: 36194940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed antibody and T cell responses to peanut and the peanut allergens Ara h 1, Ara h 2, Ara h 3 and Ara h 6 in an oral sensitization model.
    van Wijk F; Hartgring S; Koppelman SJ; Pieters R; Knippels LM
    Clin Exp Allergy; 2004 Sep; 34(9):1422-8. PubMed ID: 15347376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens.
    Storni F; Zeltins A; Balke I; Heath MD; Kramer MF; Skinner MA; Zha L; Roesti E; Engeroff P; Muri L; von Werdt D; Gruber T; Cragg M; Mlynarczyk M; Kündig TM; Vogel M; Bachmann MF
    J Allergy Clin Immunol; 2020 Apr; 145(4):1240-1253.e3. PubMed ID: 31866435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary medium-chain triglycerides promote oral allergic sensitization and orally induced anaphylaxis to peanut protein in mice.
    Li J; Wang Y; Tang L; de Villiers WJ; Cohen D; Woodward J; Finkelman FD; Eckhardt ER
    J Allergy Clin Immunol; 2013 Feb; 131(2):442-50. PubMed ID: 23182172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting CD22 on memory B cells to induce tolerance to peanut allergens.
    Hardy LC; Smeekens JM; Raghuwanshi D; Sarkar S; Daskhan GC; Rogers S; Nycholat C; Maleki S; Burks AW; Paulson JC; Macauley MS; Kulis MD
    J Allergy Clin Immunol; 2022 Dec; 150(6):1476-1485.e4. PubMed ID: 35839842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4(+) CD25(+) T regulatory cells do not transfer oral tolerance to peanut allergens in a mouse model of peanut allergy.
    Marcondes Rezende M; Hassing I; Bol-Schoenmakers M; Bleumink R; Boon L; van Bilsen J; Pieters R
    Clin Exp Allergy; 2011 Sep; 41(9):1324-33. PubMed ID: 21338425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy.
    Bannon GA; Cockrell G; Connaughton C; West CM; Helm R; Stanley JS; King N; Rabjohn P; Sampson HA; Burks AW
    Int Arch Allergy Immunol; 2001; 124(1-3):70-2. PubMed ID: 11306930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain-dependent induction of allergic sensitization caused by peanut allergen DNA immunization in mice.
    Li X; Huang CK; Schofield BH; Burks AW; Bannon GA; Kim KH; Huang SK; Sampson HA
    J Immunol; 1999 Mar; 162(5):3045-52. PubMed ID: 10072557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells.
    Srivastava KD; Qu C; Zhang T; Goldfarb J; Sampson HA; Li XM
    J Allergy Clin Immunol; 2009 Feb; 123(2):443-51. PubMed ID: 19203662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of peanut allergy with a novel Ara h 2-Fcγ fusion protein in mice.
    Liu Y; Sun Y; Chang LJ; Li N; Li H; Yu Y; Bryce PJ; Grammer LC; Schleimer RP; Zhu D
    J Allergy Clin Immunol; 2013 Jan; 131(1):213-21.e1-5. PubMed ID: 23199607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peanut-specific T cell responses in patients with different clinical reactivity.
    Birrueta G; Tripple V; Pham J; Manohar M; James EA; Kwok WW; Nadeau KC; Sette A; Peters B; Schulten V
    PLoS One; 2018; 13(10):e0204620. PubMed ID: 30304054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.